All Stories

  1. The carbon footprint of respiratory treatments in Europe and Canada: an observational study from the CARBON programme

    Article • European Respiratory Journal, July 2022, European Respiratory Society (ERS)

    Christer Janson

  2. Short-acting ß2-agonists and greenhouse gas emissions in Europe and Canada

    Article • September 2021, European Respiratory Society (ERS)

    Christer Janson

  3. Osteoporosis and fracture risk associated with inhaled corticosteroid use among Swedish COPD patients: the ARCTIC study

    Article • European Respiratory Journal, September 2020, European Respiratory Society (ERS)

    Christer Janson

  4. Pharmacological management and risk of mortality after first COPD hospitalization (HERA)

    Article • September 2020, European Respiratory Society (ERS)

    Christer Janson

  5. Use of Machine learning to predict asthma exacerbations

    Article • September 2020, European Respiratory Society (ERS)

    Christer Janson

  6. Testing bronchodilator responsiveness

    Article • European Respiratory Journal, December 2019, European Respiratory Society (ERS)

    Christer Janson, Andre FS Amaral

  7. A Cross-Sectional Study Assessing Appropriateness Of Inhaled Corticosteroid Treatment In Primary And Secondary Care Patients With COPD In Sweden

    Article • International Journal of Chronic Obstructive Pulmonary Disease, November 2019, Taylor & Francis

    Johanna Sulku, Christer Janson, Marieann Högman

  8. Late Breaking Abstract - SABA overuse and risk of mortality in a nationwide Swedish asthma cohort (HERA)

    Article • September 2019, European Respiratory Society (ERS)

    Christer Janson

  9. Use of short-acting beta-2 agonists (SABA) and exacerbations in a nationwide Swedish asthma cohort (HERA)

    Article • September 2019, European Respiratory Society (ERS)

    Christer Janson

  10. Different Relationships between FENO and COPD Characteristics in Smokers and Ex-Smokers

    Article • COPD Journal of Chronic Obstructive Pulmonary Disease, July 2019, Taylor & Francis

    Marieann Högman, Christer Janson

  11. Lost in the transition from pediatric to adult healthcare? Experiences of young adults with severe asthma

    Article • Journal of Asthma, July 2019, Taylor & Francis

    Christer Janson, Erik Melén

  12. Bronchodilator reversibility in asthma and COPD: findings from three large population studies

    Article • European Respiratory Journal, June 2019, European Respiratory Society (ERS)

    Christer Janson, Andre FS Amaral

  13. Sex-related differences in management of Swedish patients with a clinical diagnosis of chronic obstructive pulmonary disease

    Article • International Journal of Chronic Obstructive Pulmonary Disease, May 2019, Dove Medical Press

    Christer Janson

  14. Impact of COPD diagnosis timing on clinical and economic outcomes: the ARCTIC observational cohort study

    Article • International Journal of Chronic Obstructive Pulmonary Disease, May 2019, Dove Medical Press

    Dr. Konstantinos Kostikas, Christer Janson, Leif Jorgensen, Kjell Larsson

  15. Pharmacological treatment of asthma in a cohort of adults during a 20-year period: results from the European Community Respiratory Health Survey I, II and III

    Article • ERJ Open Research, February 2019, European Respiratory Society (ERS)

    Christer Janson

  16. Rationale for a Swedish cohort consortium

    Article • Upsala Journal of Medical Sciences, January 2019, Taylor & Francis

    Johan Sundström, Christer Janson, Marieann Högman, Peter Nilsson

  17. Effectiveness trials: critical data to help understand how respiratory medicines really work?

    Article • European Clinical Respiratory Journal, January 2019, Taylor & Francis

    Christer Janson

  18. Real-world evidence effect of budesonide+formoterol Spiromax on patients with asthma and chronic obstructive pulmonary disease in Sweden

    Article • European Clinical Respiratory Journal, January 2019, Taylor & Francis

    Christer Janson

  19. Influence of comorbid heart disease on dyspnea and health status in patients with COPD – a cohort study

    Article • International Journal of Chronic Obstructive Pulmonary Disease, November 2018, Dove Medical Press

    Christer Janson

  20. Prevalence, characteristics and management of frequently exacerbating asthma patients: an observational study in Sweden (PACEHR)

    Article • European Respiratory Journal, June 2018, European Respiratory Society (ERS)

    Christer Janson

  21. Factors associated with lung cancer in COPD patients

    Article • International Journal of Chronic Obstructive Pulmonary Disease, June 2018, Dove Medical Press

    Christer Janson, Kjell Larsson

  22. 2017 Global Initiative for Chronic Obstructive Lung Disease reclassifies half of COPD subjects to lower risk group

    Article • International Journal of Chronic Obstructive Pulmonary Disease, January 2018, Dove Medical Press

    Johanna Sulku, Christer Janson, Marieann Högman

  23. Changes in smoking prevalence and cessation support, and factors associated with successful smoking cessation in Swedish patients with asthma and COPD

    Article • European Clinical Respiratory Journal, January 2018, Taylor & Francis

    Christer Janson

  24. Economic burden of COPD in a Swedish cohort: the ARCTIC study

    Article • International Journal of Chronic Obstructive Pulmonary Disease, January 2018, Dove Medical Press

    Leif Jorgensen, Christer Janson, Kjell Larsson

  25. Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD

    Article • International Journal of Chronic Obstructive Pulmonary Disease, October 2017, Dove Medical Press

    Christer Janson, Kjell Larsson

  26. Pulmonary rehabilitation in COPD – available resources and utilization in Swedish primary and secondary care

    Article • International Journal of Chronic Obstructive Pulmonary Disease, June 2017, Dove Medical Press

    Christer Janson

  27. Upper airway and skin symptoms in allergic and non-allergic asthma: Results from the Swedish GA2LEN study

    Article • Journal of Asthma, May 2017, Taylor & Francis

    Christer Janson

  28. Measures of bronchodilator response of FEV1, FVC and SVC in a Swedish general population sample aged 50–64 years, the SCAPIS Pilot Study

    Article • International Journal of Chronic Obstructive Pulmonary Disease, March 2017, Dove Medical Press

    Annika Rosengren, Christer Janson, Anna-Carin Olin

  29. Assembly 6: occupation and epidemiology

    Article • Breathe, August 2016, European Respiratory Society (ERS)

    Christer Janson

  30. Vital capacity and COPD: the Swedish CArdioPulmonary bioImage Study (SCAPIS)

    Article • International Journal of Chronic Obstructive Pulmonary Disease, May 2016, Dove Medical Press

    Eeva Piitulainen, Annika Rosengren, Christer Janson, Anna-Carin Olin

  31. Sex differences in reported and objectively measured sleep in COPD

    Article • International Journal of Chronic Obstructive Pulmonary Disease, January 2016, Dove Medical Press

    Professor Thorarinn Gislason, Christer Janson

  32. The phenotype of concurrent chronic bronchitis and frequent exacerbations in patients with severe COPD attending Swedish secondary care units

    Article • International Journal of Chronic Obstructive Pulmonary Disease, October 2015, Dove Medical Press

    Professor Anders Lindén, Christer Janson, Kjell Larsson

  33. Comorbidity and health-related quality of life in patients with severe chronic obstructive pulmonary disease attending Swedish secondary care units

    Article • International Journal of Chronic Obstructive Pulmonary Disease, January 2015, Taylor & Francis

    Professor Anders Lindén, Christer Janson, Kjell Larsson

  34. Clinical COPD Questionnaire score (CCQ) and mortality

    Article • International Journal of Chronic Obstructive Pulmonary Disease, December 2012, Taylor & Francis

    Christer Janson, scott montgomery

  35. Long-term survival in patients hospitalized for chronic obstructive pulmonary disease: a prospective observational study in the Nordic countries

    Article • International Journal of Chronic Obstructive Pulmonary Disease, September 2012, Taylor & Francis

    Professor Charlotte Suppli Ulrik, Professor Thorarinn Gislason, Gunnar Gudmundsson, Christer Janson